Suchergebnisse - (Standardsuche:ritonavir)

PubPharm (24)

1

Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients

enthalten in: HIV clinical trials | 2018

von Dentone, C. | Di Biagio, A. | Cozzi Lepri, A. | +10

2

Raltegravir versus lopinavir/ritonavir for treatment of HIV-infected late-presenting pregnant women

enthalten in: HIV clinical trials | 2018

von Brites, C. | Nóbrega, I. | Luz, E. | +3

3

Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir : data from the ICONA Cohort

enthalten in: HIV clinical trials | 2018

von d'Arminio Monforte, A. | Lorenzini, P. | Cozzi-Lepri, A. | +10

4

Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain : The TRIP study

enthalten in: HIV clinical trials | 2015

von Pedrol, E. | Caro-Murillo, A. | Castaño, M. | +11

5

Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects : the progress study, 48-week results

enthalten in: HIV clinical trials | 2011

von Reynes, J. | Lawal, A. | Pulido, F. | +6

6

Comparative effectiveness of efavirenz, protease inhibitors, and raltegravir-based regimens as first-line treatment for HIV-infected adults : a mixed treatment comparison

enthalten in: HIV clinical trials | 2011

von Vieira, M. | Kumar, R. | Jansen, J.

7

Similar virologic and immunologic efficacy with fosamprenavir boosted with 100 mg or 200 mg of ritonavir in HIV-infected patients : results of the LESS trial

enthalten in: HIV clinical trials | 2010

von Cohen, C. | Dejesus, E. | Lamarca, A. | +7

8

Comparative cost-efficacy analysis of darunavir/ritonavir and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in the United States

enthalten in: HIV clinical trials | 2010

von Brogan, A. | Mrus, J. | Hill, A. | +2

9

Study of once-daily versus twice-daily fosamprenavir plus ritonavir administered with abacavir/lamivudine once daily in antiretroviral-naïve HIV-1-infected adult subjects

enthalten in: HIV clinical trials | 2009

von Carosi | Lazzarin | Stellbrink | +9

10

Cost-effectiveness of tipranavir in treatment-experienced HIV patients in the United States

enthalten in: HIV clinical trials | 2008

von Simpson, K. | Roberts, G. | Hicks, C. | +1